Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
PharmTech
CPhI North America
Preview of Day 2:
Wednesday, May 1, 2019
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

Welcome to your inside look into CPhI North America 2019. See below for the second day's events. Go to www.cphinorthamerica.com for more details.

Visit Pharmaceutical Technology at Booth 2446.


 

HIGHLIGHTS

Keynote—Artificial Intelligence: Buzz Word or Industry Changer?

Wednesday, May 1, 1:30pm–2:15pm

Brandon Allgood, chief technology officer and cofounder of Numerate, gives his perspective on artificial intelligence, the future of machine learning, and why the drug industry needs to take notice.
/ Read more /


Filling The Gap In Skilled Workforce Shortage In Biomanufacturing

Wednesday, May 1, 11:45pm–12:30pm

This presentation will focus on the shortage of skilled workforce in biomanufacturing and the efforts of industry-academic partnerships/initiatives to define industry needs and develop strategies to solve the skills gap.
/ Read more /

McCormick Place, Chicago, IL

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers		 subscribe

SCHEDULE OF EVENTS FOR MAY 1

Exhibits

Wednesday, May 1, 10:00am–5:00pm

Insight Briefings

Wednesday, May 1, 10:30am–2:15pm

Conference Sessions

Wednesday, May 1, 9:45am–3:45pm

Exhibitor Showcases

Wednesday, May 1, 10:30am–4:15pm

 

NEWS

Hovione Technology Acquires Rights to New Blister-Based Inhaler

Hovione Technology has acquired global rights to a dry powder inhaler for pulmonary drug delivery, the Papillon DPI invented by Dr. Klaus-Dieter Beller.
/ Read more /


Cambrex Doubles Liquid-Filling Capacity at Québec Facility

The company will add a cGMP packaging line and a new filler on its existing packaging line at its Mirabel, Québec, Canada, site.
/ Read more /


WuXi Biologics Completes First Routine FDA Inspection, Announces Partnership Plans

The company passed a seven-day FDA surveillance GMP inspection and announced two upcoming manufacturing partnerships.
/ Read more /


Catalent to Acquire Paragon Bioservices for $1.2 Billion

Catalent's acquisition of Paragon Bioservices will provide expertise in expanding gene therapy market.
/ Read more /

 

LATER THIS WEEK AT CPhI NORTH AMERICA

Exhibits

Thursday, May 2, 10:00am–3:00pm

Conference Sessions

Thursday, May 2, 9:00am–12:30pm

contribute | contact editors | CONTACT SALES | subscribe | advertise